HVJ-E solution

3 trials

Sponsors

Department of Dermatology Osaka University Graduate School of Medicine, Department of Urology, Osaka University Graduate School of Medicine

Conditions

Castration resistant prostate canceradvanced malignant melanomacastration resistant prostate cancer

Phase 1

Phase I/II clinical trial of inactivated HVJ-E administration for advanced malignant melanoma patients

JPRN-UMIN000002376

Department of Dermatology Osaka University Graduate School of Medicineadvanced malignant melanoma

Start: 2009-07-01Target: 6Updated: 2026-06-29

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients

RecruitingJPRN-UMIN000006142

Department of Urology, Osaka University Graduate School of MedicineCastration resistant prostate cancer

Start: 2011-10-01Target: 12Updated: 2026-06-29

Clinical trial of subsequent injection of HVJ-E to those patients who enrolled in the clinical trial of ' Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients '

RecruitingJPRN-UMIN000010840

Department of Urology, Osaka University Graduate School of Medicinecastration resistant prostate cancer

Start: 2013-06-01Target: 9Updated: 2026-06-29

Related Papers

Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial

Cancer Immunology Immunotherapy2024-10-033 citations

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.

2017-05-1214 citations